An international consortium of clinicians coordinated by the Strasbourg Reference Centre looked at patients with inflammatory myopathy with regard to two uncommon clinical signs:
- camptocormia and/or head droop syndrome in 49 patients with inflammatory myopathy,
- their clinical and biological data were compared with those of 98 patients with inflammatory myopathy but without these two signs,
- in these 49 patients, who were older on average and had a poorer prognosis, there was a higher rate of scleromyositis, more frequent dysphagia and higher mortality.